P46377 4th Annual Clinical Trials
Download Brochure Request

Register your interest


Register your interest


4th Annual Clinical Trials

15 – 16 May 2019, Shanghai Marriott Hotel Parkview, China

Register Your Interest Download Brochure



Recent regulatory developments have invigorated China’s clinical trials industry. Greater flexibility to encourage innovation, the 60 day CDE timeline for Phase 3 trials, site accreditation process revamp, acceptance of foreign data towards new drug applications, are just some of the measures expected to generate renewed enthusiasm amongst foreign and local sponsors.

IBCs 4th Annual Clinical Trials conference is part of the 5th Biopharma Development and Production Week in China. It will address market opportunities, growth trends, process innovation, technology and digitization. The hottest developments in relation to CAR-T trials and the oncology market will get additional focus.

Discussion themes

  • Trends and growth opportunities in China’s trial activities in context to therapeutic areas, disease burden, and impact of top industry sponsors
  • Interpreting and working with recent regulations
  • Sponsor perspectives on market outlook and expectations from CROs
  • The emergence of CDMOs and implications for the clinical trail industry
  • Digitalization touch points in clinical trials
  • AI in drug discovery and dealing with clinical data
  • Process and technology innovations in the Oncology trial space
  • CART-Trials, opportunities, requirements and best practice
  • Biosimilar trails – innovation, new developments and future direction for this market
  • Authorization procedures in various jurisdictions
  • Working with standards for good clinical practices
  • Reporting and disclosure requirements
  • Informed consent obligations
  • Insurance requirements
  • Data protections issues

Part of

5th Annual BioPharma Development and Production Week »

With demonstrated success year on year, IBCs BDP Week in China enjoys unparalleled industry support. Known for generating knowledge, creating business opportunities, and bringing innovative ideas to the table, the BDP Week is now more impactful than ever with 5 high level conferences, learning seminars, focused trade show and business matching to boot.

Co located conferences

The BDP Party!

When: Wednesday, 15 May 2019 at 6.30pm
Where: Shanghai City Bistro, Level 1, Shanghai Marriott Parkview Hotel
Cost: CNY 350 / USD 50 net (inclusive of buffet dinner and free flow wine / beer)

  • Registration is not limited to conference participants and we encourage all who are in the BDP industry to attend.
  • Dinner will only proceed when we have reached 100 participants.
  • Payment is only required when the dinner is confirmed.
  • Participants list for the dinner will be made available online once the registration reaches 100 participants.

CNY Pricing

  • 2 Day Conference: CNY 6,500
  • Group of 2 or more delegates: CNY 5,000
  • Group of 4 or more delegates: CNY 4,500
  • Pre Conference Workshop: CNY 1,000
  • Gala Dinner: CNY 350


Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>


Judith Li

Partner, Lilly Asia Ventures, Hong Kong

Feng Tao

Founding Partner, Biotrack Capital, China

He Ting

Chief Executive Officer, ImmunoChina, China

Dong Wei

CEO, Edigene, China

Peter Luo

CEO, Adagene Pharma, China

Jonathan Zhao 4th Annual Bioprocess and Technology 2018

Jonathan Zhao

Co-Founder and Executive Chairman, TRANSCENTA HOLDING, China

Dr. Xin Zhang

Vice President of Global Clinical Operations and Affairs, Shanghai Henlius Biotech, Inc., China

Ting He

Chief Executive Officer, ImmunoChina, China

Hei Yongjiang

Chief Medical Officer, Oncology, Zai Laboratory, China

Jennifer Harmon

Director, Clinical Affairs, SynAgile, Singapore

Dr. Alvin Luk

Senior Vice President and Chief Medical Officer, Shanghai Henlius Biotech, Inc., China

Joanne Chio

Head, Clinical Trials - Healthcare Services, National University Hospital Singapore, Singapore

Xiaorui Wang

VP of Regulatory Affairs & Clinical Development Zensun, China

Dr Jean-Louis Excler

Program Director, New Initiatives, International Vaccine Institute, Republic of Korea

Eddy Wu

China Head/Vice-President, Terns Pharmaceutical, China

James Cheng-Chung Wei

Professor, Institute of Medicine, Chief, Division of Allergy, Immunology and Rheumatology, Director, Chinese Medicine Clinical Trial Center, Chung Shan Medical University Hospital, Taiwan

Rong Chen

Chief Medical Officer, JHL Biotech, China

Dr Jerry Dong

Vice President of CMC and Regulatory Affairs, Shanghai Henlius Biotech, Inc.

Chen-Yuan Lin

Ward Director and Attending Physician at the Division of Hematology and Oncology, China Medical University Hospital, Taiwan

Dr Lin Shiwen

Vice President of Downstream Process Development, WuXi Biologics, China

Dr. Jerry Yang

Senior Vice President, Process & Product Development, Hangzhou JUST Biotherapeutics, China

when & where

15 - 16 May 2019

Shanghai Marriott Hotel Parkview
333 Guang Zhong Road West, Jing’an District
Shanghai, 200072 China
Phone:+86 21 3669 8888
Fax:+86 21 3669 8668

Cartrina Wang 王洁琼 | Senior Sales Manager-EBC
T: 86 21 3669 8666 | M:13585605981



Still have a question?

Speaking Opportunities
Sheralin See
+65-6508 2442

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489


Media & Association Partnership Opportunities
Tham Ruohyi
+65 6508 2463




Conference Partner Conference Partner


IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more